Senior Consultant for Clinical & Medical Affairs
Malcolm Barratt-Johnson is a physician with over 18 years’ pharmaceutical experience in Medical and Regulatory affairs.
With extensive international experience in both industry and governmental bodies, Malcolm brings significant expertise in the areas of clinical development plans, pharmacovigilance review, and regulatory strategy and compliance. During his career, he has led decision-making in the medical and marketing departments of six top ten Pharmaceutical Companies – including Pfizer and AstraZeneca – and advised both the biotech and generic sectors.
As a former Lead Medical Assessor at the MHRA, Malcolm advised on over 400 clinical trials in all clinical disciplines, including advanced biological compounds. As a Medical Assessor to the Medicines Control Agency, he licensed 130 medicines under national/centralised procedures, and presented 28 papers to the Committee on Safety of Medicines (CSM). He delivered primary medical input for the launch of key products in neurosciences and oncology, and has considerable experience in the respiratory, anaesthesia and women's health sectors.
Malcolm is an Immediate Past President of the Section of Pharmaceutical Medicine and Research of the Royal Society of Medicine, and is a Lecturer on the MSc Courses of Surrey and Copenhagen.